| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 98.9515 | 75 |
| GSM780708 | Untreated after 4 days (C2_1) | 107.85 | 76 |
| GSM780709 | Untreated after 4 days (C3_1) | 89.0617 | 73 |
| GSM780719 | Untreated after 4 days (C1_2) | 92.8993 | 74 |
| GSM780720 | Untreated after 4 days (C2_2) | 105.119 | 76 |
| GSM780721 | Untreated after 4 days (C3_2) | 102.064 | 76 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 109.981 | 77 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 98.1495 | 75 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 112.167 | 77 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 112.54 | 77 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 108.627 | 76 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 104.866 | 76 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 89.9717 | 74 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 97.5452 | 75 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 91.3387 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 81.3601 | 72 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 91.641 | 74 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 86.1563 | 73 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 131.962 | 79 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 114.202 | 77 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 104.642 | 76 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 106.732 | 76 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 115.522 | 77 |